Results 321 to 330 of about 1,425,061 (397)

The OtR tumor recurrence and metastasis model reveals doxorubicin‐induced tumor shrinkage doesn't guarantee prolonged survival

Animal Models and Experimental Medicine, EarlyView.
Tumor growth inhibition does not predict survival benefit in a clinically relevant metastasis model. Tumor local growth and systemic metastasis represent distinct biological processes. In the 4T1‐OtR model, although chemotherapy significantly suppresses primary tumor growth, it fails to prevent distant metastasis or extend overall survival.
Lingli Luo, Ling Liu, Minyao Deng, Yong Jiang, Chuan Liu, Xiang Chen, Xiaoxi Li   +6 more
wiley   +1 more source

Adjuvant chemotherapy before osimertinib in <i>EGFR</i>-mutated stage IB lung adenocarcinoma: a clinical dilemma. [PDF]

Transl Lung Cancer Res
Park SH, Park JH, Kim TH, Choi SH, Park JE, Kim I, Kim JY, Kim TH, Lee T, Cho HK, Jeong JH, Yang JW, Lee HK, Lee HY, Jung HJ, Eom JS, Ahn JH.   +16 more
europepmc   +1 more source

Engineering Tertiary Lymphoid Structures: Nanomedicine, Bioengineering, and Biomaterials for Precision Immunotherapy

Advanced NanoBiomed Research, EarlyView.
This review explains how biomaterials and nanoparticles can be used to induce or modulate tertiary lymphoid structures (TLSs), which are ectopic immune hubs that form in nonlymphoid tissues during chronic disease and cancer. By comparing different methods, the article highlights design principles for modeling TLSs or recapitulating specific TLS ...
Shaza Karaman, Mei ElGindi, Jeremy Teo
wiley   +1 more source

The efficacy of adjuvant chemotherapy after total mesorectal excision without selective lateral lymph node dissection for locally advanced rectal cancer. [PDF]

Sci Rep
Kameishi S, Yamaguchi T, Hamamoto H, Okemoto D, Matsuo N, Ikegami T, Kodama H, Yukami H, Fakhrejahani E, Lee SW, Nishikawa H.   +10 more
europepmc   +1 more source

Critically appraised paper: In adults following adjuvant chemotherapy for colon cancer, a 3-year exercise program increased disease-free survival and overall survival compared with health education [commentary]

Amy M Dennett
openalex   +1 more source

Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

Advanced NanoBiomed Research, EarlyView.
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari, Yunhui Min, Eun‐Ju Ko, Doyoung Kwon, Rehan Khan, Young‐Ok Son   +5 more
wiley   +1 more source

Association Between Fragmentation of Care and Delivery of Adjuvant Chemotherapy in Patients Traveling to High-Volume Hospitals for Pancreatic Adenocarcinoma. [PDF]

Ann Surg Oncol
Hughes AJ, Kaiser KN, Holler E, Ruedinger BM, Turk AA, Schlick CJR, House MG, Y Bilimoria K, Ellis RJ.   +8 more
europepmc   +1 more source

Nutritional Status, Muscle Mass, and Body Fat Percentage in Patients with Breast Cancer Undergoing Adjuvant Chemotherapy

Aichetou Bouh, Slimane Mehdad, Nouriya El Ghoulam, Daoud Daoudi, Souad Benaich, Aicha Madkour, Hassan Errihani, Saber BOUTAYEB   +7 more
openalex   +1 more source

Bacterial Pigments as Potential Antitumor Agents Against Gastrointestinal Cancers: A Comprehensive Systematic Review

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Gastrointestinal cancers (GICs) constitute one of the leading causes of cancer‐related morbidity and mortality worldwide. Despite currently available therapeutic strategies, new approaches and procedures are needed for their prevention and treatment.
Raúl Vergara, Ricardo F. S. Pereira, Carla C. C. R. de Carvalho, Jose Prados, Consolación Melguizo, Raul Ortiz   +5 more
wiley   +1 more source

Adjuvant Chemotherapy in Breast Cancer after Neoadjuvant Therapy: Essential or Optional? [PDF]

Cancer Res Treat
Zhang D, Yang L, Zheng Y, Zhou Q.
europepmc   +1 more source